Literature DB >> 9120946

Angiosarcoma of the bladder after therapeutic irradiation for prostate cancer.

J D Navon1, M Rahimzadeh, A K Wong, P M Carpenter, T E Ahlering.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9120946

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Epithelioid angiosarcoma of the bladder after irradiation for endometrioid adenocarcinoma.

Authors:  A Kulaga; A Yilmaz; R P Wilkin; K Trpkov
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

2.  Post-radiation epithelioid angiosarcoma of the urinary bladder and prostate.

Authors:  Gang Wang; Peter C Black; Brian F Skinnider; Malcolm M Hayes; Edward C Jones
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

3.  Primary angiosarcoma of the bladder in a young female.

Authors:  Richard R Warne; Jeremy S L Ong; Bret Snowball; Justin B Vivian
Journal:  BMJ Case Rep       Date:  2011-04-01

Review 4.  Prostate angiosarcoma: a case report and literature review.

Authors:  Waseem Khaliq; Christian F Meyer; Ikechukwu Uzoaru; Richard M Wolf; Emmanuel S Antonarakis
Journal:  Med Oncol       Date:  2012-02-17       Impact factor: 3.064

Review 5.  Prostate angiosarcoma: is there any association with previous radiation therapy?

Authors:  Waseem Khaliq; Christian F Meyer; Ikechukwu Uzoaru; Richard M Wolf; Emmanuel S Antonarakis
Journal:  BJU Int       Date:  2012-05-15       Impact factor: 5.588

6.  Primary angiosarcoma of urinary bladder: 13th reported patient.

Authors:  Zaher Bahouth; Ismael Masarwa; Sarel Halachmi; Ofer Nativ
Journal:  Case Rep Oncol Med       Date:  2015-01-26

7.  Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.

Authors:  Shijie Li; Xuefeng Liu; Xiaonan Chen
Journal:  BMC Urol       Date:  2021-11-25       Impact factor: 2.264
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.